Harrow (HROW) Total Current Liabilities (2010 - 2026)
Harrow (HROW) recorded quarterly Total Current Liabilities of $91.4 million in Q1 2026, down 5.05% quarter-over-quarter from $96.3 million in Q4 2025, and down 51.1% on a YoY basis from $187.0 million in Q1 2025.
Harrow (HROW) Total Current Liabilities (2010 - 2026) Analysis & Trends
Harrow's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $91.4 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 51.1% year-over-year to $91.4 million; the TTM figure through Mar 2026 stood at $91.4 million (down 51.1% YoY), while the FY2025 annual figure was $96.3 million, up 5.43% from the prior year.
- Total Current Liabilities was $91.4 million for Q1 2026 at Harrow, down from $96.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $248.9 million in Q2 2025 to a low of $9.2 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $67.0 million across 5 years, with a median of $49.3 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Total Current Liabilities soared 399.26% in 2024, then tumbled 51.1% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $18.6 million in 2022, then soared by 164.83% to $49.3 million in 2023, then soared by 85.11% to $91.3 million in 2024, then grew by 5.43% to $96.3 million in 2025, then decreased by 5.05% to $91.4 million in 2026.
- The last three Total Current Liabilities figures came in at $91.4 million (Q1 2026), $96.3 million (Q4 2025), and $65.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | 91.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.44 Mn |
| Dec 31, 2025 | 96.30 Mn |
| Sep 30, 2025 | 65.40 Mn |
| Jun 30, 2025 | 248.88 Mn |
| Mar 31, 2025 | 186.99 Mn |
| Dec 31, 2024 | 91.34 Mn |
| Sep 30, 2024 | 95.01 Mn |
| Jun 30, 2024 | 53.55 Mn |
| Mar 31, 2024 | 41.75 Mn |
| Dec 31, 2023 | 49.34 Mn |
| Sep 30, 2023 | 19.03 Mn |
| Jun 30, 2023 | 23.01 Mn |
| Mar 31, 2023 | 17.71 Mn |
| Dec 31, 2022 | 18.63 Mn |
| Sep 30, 2022 | 18.37 Mn |
| Jun 30, 2022 | 12.92 Mn |
| Mar 31, 2022 | 9.18 Mn |
| Dec 31, 2021 | 9.72 Mn |
| Sep 30, 2021 | 10.48 Mn |
| Jun 30, 2021 | 8.14 Mn |